In a significant move to revolutionise clinical research in India, Novo Nordisk India Pvt Ltd and Sher-i-Kashmir Institute of ...

Key Market Players in the Indian Diabetes Care Market include Sanofi, Novo Nordisk India, USV, Novartis, Merck, Becton ...

Eli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing ...

He also accused the Danish makers of Ozempic and Wegovy, Novo Nordisk, of "counting on selling it to Americans, because we're ...

picture alliance / Contributor / Getty Images Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' weight-loss drugs in ...

"This is an important step forward for patients," Novo Nordisk said in a statement commenting on the proposal, adding that the coverage could become effective in 2026. Alexander Jenke, a portfolio ...

Novo Nordisk (NVO) has released an update. Don't Miss our Black Friday Offers: Novo Nordisk has initiated a significant share repurchase program, aiming to buy back up to DKK 20 billion worth of B ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other profitable European stocks. After the U.S. Presidential elections, the global economies ...

Team India are gearing up for a crucial five-match Test series against Australia, aiming to secure a historic hat-trick of series wins Down Under. A 4-0 or 5-0 victory would guarantee India a spot ...

Novo Nordisk, the maker of weight-loss drugs Ozempic and Wegovy, is suing at least five Chicago-area medical spas and health clinics, alleging they each are using false advertising and deceptive ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions online, despite a lack of evidence that they work. Now, though, on ...